Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2309 ARTÍCULOS , VIENDO DEL 1186 AL 1200

Delirium and Dementia in the Elderly: Sometimes Associated or Always Together?

Bugiani O.

Eur Neurol. 2023;86(3):161-165. doi: 10.1159/000530226. Epub 2023 Mar 23.

Editorial: Association of metabolic diseases with cognition impairment and dementia

Luan S, Zhou J.

Front Endocrinol (Lausanne). 2023 Mar 10;14:1166342. doi: 10.3389/fendo.2023.1166342. eCollection 2023.

The Future of Cognitive Screening in Neurodegenerative Diseases

Umfleet LG, Bilder RM, Loring DW, Thames A, Hampstead BM, Bauer RM, Drane DL, Cavanagh L.

J Alzheimers Dis. 2023;93(1):47-59. doi: 10.3233/JAD-221077.

Insulin-like growth factor-2 is a promising candidate for the treatment and prevention of Alzheimer's disease

Fitzgerald GS, Chuchta TG, McNay EC.

CNS Neurosci Ther. 2023 Jun;29(6):1449-1469. doi: 10.1111/cns.14160. Epub 2023 Mar 27.

New Pathways Identify Novel Drug Targets for the Prevention and Treatment of Alzheimer's Disease

Penke B, Szűcs M, Bogár F.

Int J Mol Sci. 2023 Mar 11;24(6):5383. doi: 10.3390/ijms24065383.

Dietary Protection against Cognitive Impairment, Neuroinflammation and Oxidative Stress in Alzheimer's Disease Animal Models of Lipopolysaccharide-Induced Inflammation

Decandia D, Gelfo F, Landolfo E, Balsamo F, Petrosini L, Cutuli D.

Int J Mol Sci. 2023 Mar 21;24(6):5921. doi: 10.3390/ijms24065921.

How Can We Support Religious and Spiritual Practices of Older Adults With Mild Cognitive Impairment and Dementia?

Britt KC, Hamilton J.

J Gerontol Nurs. 2023 Apr;49(4):3-5. doi: 10.3928/00989134-20230309-01. Epub 2023 Apr 1.

Probiotic intervention benefits multiple neural behaviors in older adults with mild cognitive impairment

Fei Y, Wang R, Lu J, Peng S, Yang S, Wang Y, Zheng K, Li R, Lin L, Li M.

Geriatr Nurs. 2023 May-Jun;51:167-175. doi: 10.1016/j.gerinurse.2023.03.006. Epub 2023 Mar 28.

The feasibility of a multidomain dementia risk reduction randomised controlled trial for people experiencing cognitive decline: the Body, Brain, Life for Cognitive Decline (BBL-CD)

McMaster M, Kim S, Clare L, Torres SJ, Cherbuin N, Anstey KJ.

Aging Ment Health. 2023 Nov-Dec;27(11):2111-2119. doi: 10.1080/13607863.2023.2190083. Epub 2023 Mar 30.

Low blood carotenoid status in dementia and mild cognitive impairment: A systematic review and meta-analysis

Wang L, Zhao T, Zhu X, Jiang Q.

BMC Geriatr. 2023 Mar 30;23(1):195. doi: 10.1186/s12877-023-03900-7.

A comprehensive perspective of autistic traits and catatonic symptoms in a patient with Fronto-Temporal Dementia and Bipolar Disorder: a case report

Dell'Osso L, Chiarantini I, Bonelli C, Cappellato G, Carpita B.

BMC Psychiatry. 2023 Mar 30;23(1):216. doi: 10.1186/s12888-023-04709-9.

[Prevention and health promotion in dementia: motivation for change within preventive interventions-Empirical results]

Thyrian JR.

Nervenarzt. 2023 May;94(5):375-383. doi: 10.1007/s00115-023-01480-w. Epub 2023 Apr 3.

A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress

Morató X, Marquié M, Tartari JP, Lafuente A, Abdelnour C, Alegret M, Jofresa S, Buendía M, Pancho A, Aguilera N, Ibarria M, Diego S, Cuevas R, Cañada L, Calvet A, Antonio EE, Pérez-Cordón A, Sanabria Á, de Rojas I, Nuñez-Llaves R, Cano A, Orellana A, Montrreal L, Cañabate P, Rosende-Roca M, Vargas L, Bojaryn U, Ricciardi M, Ariton DM, Espinosa A, Ortega G, Muñoz N, Lleonart N, Alarcón-Martín E, Moreno M, Preckler S, Tantinya N, Ramis M, Nogales AB, Seguer S, Martín E, Pytel V, Valero S, Gurruchaga M, Tárraga L, Ruiz A, Boada M.

Sci Rep. 2023 Apr 3;13(1):5406. doi: 10.1038/s41598-023-32515-6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias